← Recovery & Repair

ARA-290

Activates the innate repair receptor (IRR) to promote tissue repair without immunosuppressive effects of EPO.

Dr. Jonathan Snipes, MDMedically reviewed by Dr. Jonathan Snipes, MD. Last reviewed May 6, 2026.
ARA-290 dispensed by a licensed U.S. 503A compounding pharmacy

Verify us before you order

NeuroprotectionTissue RepairPain ReductionAnti-Inflammatory

What It Is

ARA-290 is an 11-amino acid peptide that activates the innate repair receptor. It was developed from erythropoietin (EPO) research but without EPO's blood-thickening effects.

How It Works

It activates repair pathways in damaged tissues, reduces inflammation, and has been shown to promote nerve repair and reduce neuropathic pain.

Who It's For

Those with neuropathy, nerve damage, or chronic pain conditions. Also used for general tissue repair and inflammation reduction.

Who Should Avoid It

Generally well-tolerated. Discuss with provider if on blood-related medications.

Ready to add ARA-290?

A licensed provider reviews every order.


Protocol & Pricing

Pharmacy Price

$80

6mg/mL, 5mL vial (30mg total)

You pay pharmacy price. No markup.

Starting Dose

20 units (1.2mg)

Form

Injectable vial, 5mL


Your pharmacy label will read

ARA290

6 MG/ML (5 ML)

The label shows strength per mL, not the total in the vial.

What that means

  • 6mg/mL means 6mg in every mL.
  • The vial holds 5mL, so 6mg/mL × 5mL = 30mg in the vial.
  • Each 20-unit injection (0.2mL) gives you 1.2mg, about 25 injections per vial.

Dosing Protocol

20 units subcutaneous injection daily. 20 units = 0.2mL × 6mg/mL = 1.2mg per injection. 4 to 12 weeks duration, may be cycled or extended.

Beyond Use Date

90 Days from compounding (USP <797>)

A licensed U.S. 503A compounding pharmacy assigns this date and prints it on your vial label. Always follow the label.

Ready to add ARA-290?

A licensed provider reviews every order.


Stacking Guide

Stacks Well With

BPC-157GHK-Cu

Ready to add ARA-290?

A licensed provider reviews every order.


EPO-derived repair peptide protocol

Read the ARA-290 protocol guide

An 11-amino-acid fragment of erythropoietin that triggers tissue repair without EPO's blood-thickening effect. Human evidence is small Phase 2 neuropathy trials. Honest about where the data stops.

Read guide

Related Peptides


Independently tested

ARA-290 certificate of analysis

All 3 ARA-290 samples tested for sterility and endotoxin passed both. Latest sample received by the lab Oct 2, 2026.

Every ARA-290 batch dispensed by a licensed U.S. 503A compounding pharmacy is independently tested by Eagle Analytical Services (FDA-registered, A2LA ISO 17025 accredited). Sterility testing checks that nothing grows in the sample; the USP <85> endotoxin test checks for bacterial toxins that can cause fever. Below is the lab's own report for each of the 3 most recent lots.

Lot LG342011072, received Oct 2, 2026

Sterility
PassCelsis Sterility Test. Started Oct 2, 2026, completed Oct 12, 2026. Method suitability ETX-251029-0110
Bacterial endotoxin
PassUSP <85>. Measured <2 EU/mL, limit 500 EU/mL. Started Oct 4, 2026, completed Oct 4, 2026
Sample, as printed
ARA290 6 MG/ML (5 ML) Injection
Lot #
LG342011072
Storage
Refrigerated
Received by lab
Oct 2, 2026
Laboratory
Eagle Analytical Services Inc., Houston, TX
Submission #
ETX-261002-0419
Signed
Alison Eng, Quality Control Manager
Scan of Eagle Analytical report ETX-261002-0419 for lot LG342011072. Opens the original PDF.
Eagle Analytical report ETX-261002-0419. Open the original PDF (opens in a new tab)

Eagle Analytical Services is an independent FDA-registered laboratory, A2LA accredited to ISO 17025, based in Houston, Texas. They have no commercial relationship with Rx Peps Direct. Rx Peps Direct prescribes; the pharmacy compounds and dispenses; Eagle tests every batch. Three separate companies. Results apply only to the tested sample as received. Browse our full quality program on the quality page.

Ready to add ARA-290?

A licensed provider reviews every order.


How to get ARA-290 prescribed online

ARA-290 is available by prescription after an online medical review and dispensed for human use by a licensed 503A pharmacy. That is what separates it from research-use-only vials sold without a prescription. There is no membership, just a medical review fee per order, and automatic refills are optional.

  1. 1

    Complete a $39 medical review. Answer a short intake about your health history and your goals for ARA-290. The $39 fee is the only charge Rx Peps Direct collects, paid once, not a recurring subscription.

  2. 2

    A licensed provider reviews it. A US-licensed clinician reviews your intake and, if ARA-290 is appropriate for you, writes a patient-specific prescription. The starting dose is typically 20 units (1.2mg).

  3. 3

    The pharmacy compounds and ships it. A licensed 503A compounding pharmacy in Texas compounds ARA-290 and ships it pre-reconstituted by FedEx overnight in a reusable cooled case. Your fill is a 5mL injectable vial at 6mg/mL (30mg total), labeled "ARA290 6 MG/ML (5 ML)", and you pay the pharmacy $80 per vial at wholesale, with no clinic markup, plus a $15 flat FedEx overnight shipping fee charged by the pharmacy.

Rx Peps Direct prescribes ARA-290 in the 28 states plus Washington, DC where its medical team is licensed. Start your $39 medical review or browse the full Recovery & Repair range. Comparing services first? See how Rx Peps Direct stacks up against seven other providers in our best telehealth for compounded peptides comparison.

Ready to add ARA-290?

A licensed provider reviews every order.


Common questions about ARA-290

What is ARA-290?
ARA-290 (also known as cibinetide) is an 11-amino acid peptide derived from erythropoietin (EPO) but with the EPO segment removed that triggers red blood cell production. The remaining sequence binds the innate-repair receptor on tissues, promoting nerve repair and reducing inflammation without the polycythemia risks of EPO. ARA-290 has been studied for diabetic neuropathy, sarcoidosis, and chronic neuropathic pain.
Does ARA-290 work for nerve pain and inflammation?
Phase II clinical trials showed ARA-290 reduced neuropathic pain scores in patients with sarcoidosis-associated small fiber neuropathy and improved corneal nerve fiber density in diabetic neuropathy. The peptide has not progressed to FDA approval but compounding-clinic use draws on the trial-evidence base. Effects are gradual; most protocols run at least 4 weeks before assessment.
How is ARA-290 dosed?
Common subcutaneous protocols deliver 1 to 4 mg per day for 4 to 8 weeks at a time. A licensed U.S. 503A compounding pharmacy compounds ARA-290 against Rx Peps Direct prescriptions; your provider sets the dose based on the specific neuropathic indication and your medical history.
Where do I inject ARA-290?
Subcutaneously into the abdomen, upper outer thigh, or back of the upper arm using a 31-gauge, 5/16-inch (8 mm) needle on a U-100 insulin syringe. Sterile syringes are included with every Rx Peps Direct shipment. Rotate sites between injections.
How is ARA-290 supplied?
Compounded by a licensed U.S. 503A compounding pharmacy under a patient-specific prescription. Ships pre-reconstituted and ready to inject in cold-chain packaging. Every batch is tested by Eagle Analytical Services; the Certificate of Analysis is published on this product page.

Ready to add ARA-290?

A licensed provider reviews every order.